Abstract
The co-operation between industry and academia in Sweden has been subject to changing views in the society. The experiences of Astra Läkemedel AB are described and placed in a more general perspective. The co-operation in drug development includes the testing of biological hypotheses, drug formulation, preclinical and clinical studies, etc. An interesting way of collaboration is the position of 'adjunct professor'. Some problems and concerns relating to these kinds of co-operation are discussed. It is concluded that co-operation is very useful, provided that one is aware of possible pitfalls.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
